Michael Kramarz works as an analyst at Samlyn Capital, an employee owned hedge fund sponsor which manages hedge funds for its clients, invests in public equity markets across the globe, and primarily invests in value stocks of companies. Prior to working at Samlyn Capital, Michael Kramarz worked as a strategy intern at Celgeen Cellular Therapeutics and HealthpointCapital.
Kramarz earned his MD from the University of Pennsylvania School of Medicine. He earned his MBA in Healthcare Management from the Wharton School. Kramarz received a BSE in biomedical engineering from Duke University.
Egen Atkinson focuses on biotechnology and pharmaceutical investments in Venrock’s New York office. Prior to joining Venrock, Egen worked at ForSight Vision4 (acquired by Roche), where he helped launch and manage a phase I clinical trial for Age-Related Macular Degeneration. He also consulted on gene therapy pipeline development for Spark Therapeutics (Nasdaq: ONCE) prior to IPO. Egen has designed and/or conducted several nationally-presented clinical research studies at the Scheie Eye Institute, Hospital for Special Surgery, and Retina Institute of Hawaii.
Egen earned his MD from the University of Pennsylvania School of Medicine, where he graduated Alpha Omega Alpha and received the Spencer Morris Prize, awarded to the top graduating student in the class. He earned his MBA in Healthcare Management from the Wharton School, where he received a Kaiser Fellowship. Egen received his AB in Economics from Harvard University, where he played 4 years of NCAA Division I water polo, served as co-captain, and received the Collegiate Water Polo Association Scholar-Athlete of the Year award.
Alex Rosen focuses on healthcare investments in Venrock’s New York office. Prior to joining Venrock, Alex earned an MD from the University of Pennsylvania School of Medicine, where he was elected to the Alpha Omega Alpha Honor Medical Society and the Gold Humanism Honor Society. He also earned an MBA in Health Care Management from the Wharton School, where he graduated with Honors and received a Kaiser Fellowship. He has published several articles in research journals and received Penn Med’s James B. Couch Prize for achievements in the dual disciplines of medicine and business.
In addition to his clinical training, Alex did internships at McKinsey & Company and in business development at Regeneron Pharmaceuticals, Inc.
He earned an AB in Economics from Princeton University, where he served as Class President for all four years, conducted independent research in health economics, and received the Moses Taylor Pyne Honor Prize, the highest general distinction conferred on an undergraduate.